NPCE
NASDAQ HealthcareNeuropace, Inc. - Common Stock
Medical Devices
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
๐ Market Data
| Price | $17.07 |
|---|---|
| Volume | 152,490 |
| Market Cap | 579.53M |
| Beta | 1.880 |
| RSI (14-Day) | 74.1 Overbought |
| 200-Day MA | $13.06 |
| 50-Day MA | $14.73 |
| 52-Week High | $18.98 |
| 52-Week Low | $7.56 |
| Forward P/E | -49.06 |
| Price / Book | 30.11 |
๐ฏ Investment Strategy Scores
NPCE scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (89/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ฐ Dividend Daddy (7/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find NPCE in your text
Paste any article, transcript, or post โ the tool will extract NPCE and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.